ACM
IRWD icon

Aquatic Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Aquatic Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-78,800
Closed -$686K – 1410
2024
Q1 		$686K Buy
+78,800
New +$956K 0.02% 475
2023
Q4 		– Sell
-2,000
Closed -$19K – 1475
2023
Q3 		$19K Buy
+2,000
New +$19.6K ﹤0.01% 1082
2023
Q2 		– Sell
-15,800
Closed -$166K – 1541
2023
Q1 		$166K Buy
15,800
+15,200
+2,533% +$170K 0.01% 632
2022
Q4 		$7K Sell
600
-3,000
-83% -$34K ﹤0.01% 1237
2022
Q3 		$37K Sell
3,600
-2,700
-43% -$30.6K ﹤0.01% 928
2022
Q2 		$73K Buy
+6,300
New +$74.2K 0.02% 562
2022
Q1 		– Sell
-800
Closed -$9K – 1288
2021
Q4 		$9K Buy
+800
New +$9.81K 0.02% 827

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Aquatic Capital Management's IRWD Position: Q2 2024 in Review

Aquatic Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 78,800 shares — an estimated $686K sold.

Aquatic Capital Management first reported a position in IRWD in Q4 2021 and held it in 7 quarters. The position peaked at $686K in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Aquatic Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 78,800 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $686K.
  • Aquatic Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Aquatic Capital Management's Ironwood Pharmaceuticals position peaked at $686K in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Aquatic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.